The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 14, 2019

Filed:

May. 10, 2016
Applicant:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Inventors:

Dong-Ming Shen, Edison, NJ (US);

Deping Wang, Furlong, PA (US);

XiaoXia Qian, New York, NY (US);

Bart Harper, New York, NY (US);

Meng Yang, Westfield, NJ (US);

Yingjian Bo, Beijing, CN;

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); A61K 31/513 (2006.01); C07D 401/12 (2006.01); C07D 403/04 (2006.01); C07D 405/12 (2006.01); C07D 239/38 (2006.01); C07D 239/42 (2006.01); C07D 239/52 (2006.01); C07D 487/04 (2006.01); A61P 25/28 (2006.01); A61P 25/22 (2006.01); A61P 25/18 (2006.01); A61P 25/16 (2006.01); A61P 25/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/513 (2013.01); A61P 25/06 (2018.01); A61P 25/16 (2018.01); A61P 25/18 (2018.01); A61P 25/22 (2018.01); A61P 25/28 (2018.01); C07D 239/38 (2013.01); C07D 239/42 (2013.01); C07D 239/52 (2013.01); C07D 401/12 (2013.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 487/04 (2013.01);
Abstract

The present invention is directed to pyrimidinone amide compounds which may be useful as therapeutic agents for the treatment of central nervous system and/or peripheral disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Alzheimer's, cognitive impairment, anxiety, depression, migraines, or Huntington's disease, Parkinson's disease, Parkinson's disease dementia (PDD), and other diseases associated with striatal hypofunction or basal ganglia dysfunction.


Find Patent Forward Citations

Loading…